TrialPath

Find a study

Browse recruiting studies near you — free to check, always your choice.

Match me to a study

17 studies

Recruiting now, in plain language. Every study is watched over by an independent ethics board.

  • Type 2 diabetesHeart / cardiovascular disease

    Acute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes

    Testing how drinking ketone drinks affects heart function in people with type 2 diabetes and heart

    📍 University of Texas Health Science Center at San Antonio · San Antonio, TX · Get directions →

    This study will provide insight into whether cardiac function changes with oral Ketone Esters (KE) administered to patients with Type 2 Diabetes Mellitus (T2DM) and Heart failure with reduced ejection fraction (HFrEF). Plasma ketones are avidly extracted by cardiac muscle and their uptake is not dependent upon insulin or influenced by insulin resistance.

    ✓ Study care freeEarly Phase 1Ages 18–80Learn more →
  • COPD (chronic lung disease)

    📍 Equity Medical Bowling Green · Bowling Green, KY · +2 more US sites · Get directions →

    Randomized study of single and multiple doses of BBT002 in healthy volunteers and in adult patients with chronic obstructive pulmonary disease (COPD) or chronic rhinosinusitis with nasal polyps (CRSwNP).

    ✓ Study care freePhase 1Ages 18–80Learn more →
  • Obesity / overweightHeart / cardiovascular disease

    Prevention of Progression of Prediabetes, Obesity and CV Risk

    Testing ways to stop prediabetes and obesity from getting worse

    💵 May compensate

    📍 University of Texas Health Science Center at San Antonio · San Antonio, TX · Get directions →

    The investigators are studying how to help people with prediabetes (Pre-DM) and obesity. The goal is to use new and affordable treatments to bring blood sugar levels back to normal and help participants to lose weight.

    ✓ Study care freePhase 1Ages 18+Learn more →
  • COPD (chronic lung disease)

    A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease

    Testing the safety and effects of an inhaled medicine for COPD

    📍 University of Alabama at Birmingham · Birmingham, AL · +6 more US sites · Get directions →

    This study evaluates the safety, tolerability, and activity of inhaled GDC-6988 in participants with muco-obstructive disease.

    ✓ Study care freePhase 1Ages 18+Learn more →
  • Obesity / overweightHigh blood pressureCOPD (chronic lung disease)

    Feasibility of Semaglutide in Advanced Lung Disease

    Testing whether semaglutide can be given safely to people with advanced lung disease

    📍 University of Pennsylvania Perelman School of Medicine · Philadelphia, PA · Get directions →

    The goal of this clinical trial is to learn whether semaglutide, an FDA-approved treatment for diabetes and obesity, is feasible and tolerable in patients with advanced lung disease. The main question\[s\] it aims to answer are: 1.

    ✓ Study care freePhase 1Ages 18–80Learn more →
  • Type 2 diabetesHeart / cardiovascular disease

    FES Cycling With BFR in the Spinal Cord Injury Population

    Testing a cycling exercise program with added arm-leg pressure for people with spinal cord injury

    📍 Lyndhurst Centre · Toronto, Ontario · Get directions →

    Cardiometabolic Disease (CMD) is the silent killer within the spinal cord injury/disease (SCI/D) population. Many SCI/D patients' initial CMD presentation is with a heart attack, stroke, or sudden cardiac death, highlighting the need for interventions to reduce CMD risk.

    ✓ Study care freePhase 1Ages 18–75Learn more →
  • Obesity / overweightHeart / cardiovascular disease

    Mechanisms of Semaglutide Therapy in Heart Failure Patients

    Testing how semaglutide works in people with heart failure and obesity

    📍 Greenstone Biosciences · Palo Alto, CA · +1 more US site · Get directions →

    Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, primarily used for treatment of type-2 diabetes mellitus. GLP-1 receptors are present on pancreatic islet β-cells, δ-cells and α-cells.

    ✓ Study care freePhase 1Ages 20–80Learn more →
  • Obesity / overweightHeart / cardiovascular diseaseHigh cholesterol

    Akkermansia Muciniphilia and Metabolic Side Effects of ADT

    Testing how Akkermansia gut bacteria relate to body and blood lipid changes in people with obesity

    📍 London Health Sciences Centre - Victoria Hospital · London, Ontario · Get directions →

    The overriding objectives of this study are: 1. Primary outcomes: 1.

    ✓ Study care freeEarly Phase 1Ages 18+MenLearn more →
  • Obesity / overweightHeart / cardiovascular diseaseHigh blood pressure

    Metabolic Effects of Angiotensin-(1-7)

    Testing how angiotensin-(1-7) affects body metabolism in obesity

    📍 Vanderbilt University Medical Center · Nashville, TN · Get directions →

    The overall purpose of this study is to learn more about the metabolic effects of angiotensin-(1-7) in the insulin resistant state associated with obesity. Pharmacologic approaches to increase angiotensin-(1-7) levels or its actions are currently in development for treatment of metabolic-related diseases such as obesity and type II diabetes, based on findings from animal studies.

    ✓ Study care freePhase 1Ages 18–60Learn more →
  • Heart / cardiovascular diseaseHigh blood pressureCOPD (chronic lung disease)

    : Vascular Function in Health and Disease

    Studying how blood vessel function works in health and diseases like heart problems, high blood

    📍 George E Wahlen VA Medical Center · Salt Lake City, UT · Get directions →

    Many control mechanisms exist which successfully match the supply of blood with the metabolic demand of various tissues under wide-ranging conditions. One primary regulator of vasomotion and thus perfusion to the muscle tissue is the host of chemical factors originating from the vascular endothelium and the muscle tissue, which collectively sets the level of vascular tone.

    ✓ Study care freePhase 1Ages 18+Learn more →
  • COPD (chronic lung disease)

    Hyper Polarized Xenon-129 MRI vs Xenon-133 Scintigraphy

    Comparing a lung scan that uses xenon MRI with a radioactive scan for COPD

    📍 University of Virginia Health System · Charlottesville, VA · Get directions →

    Hyper polarized Xenon-129 MRI will be directly compared to a radioactive Xe-133 scintigraphy to detect defects in lung ventilation from airflow limitation. This study is conducted as a pilot study with intention to conduct a larger clinical trial.

    ✓ Study care freePhase 1Ages 18+Learn more →
  • COPD (chronic lung disease)

    Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure

    Testing whether lung transplant first can improve lung function before bone marrow transplant for

    📍 UPMC Presbyterian · Pittsburgh, PA · +1 more US site · Get directions →

    The purpose of this study is to determine whether a lung transplantation prior to bone marrow transplantation (BMT) would allow for restoration of pulmonary function prior to BMT, allowing to proceed to BMT, to restore hematologic function.

    ✓ Study care freePhase 1Ages 18–60Learn more →
  • High blood pressureCOPD (chronic lung disease)Asthma

    Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease

    Testing a lung scan method using hyperpolarized oxygen gas MRI in healthy and people with COPD or

    📍 University of Kansas Medical Center · Kansas City, KS · Get directions →

    The purpose of this study is to develop and evaluate the usefulness of hyperpolarized (HP) 129Xe gas MRI for regional assessment of pulmonary function.

    ✓ Study care freePhase 1Ages 3+Learn more →
  • Heart / cardiovascular disease

    Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions

    Testing stem cell treatment for safety and effects on heart disease

    📍 Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites · Culver City, CA · Get directions →

    This multi-arm, multi-site study investigates the safety, tolerability, and efficacy of stem cell therapy for the treatment of various acute and chronic conditions. Clinically observed initial findings and an extensive body of research indicate regenerative treatments are both safe and effective for the treatment of multiple conditions.

    ✓ Study care freePhase 1Ages 18+Learn more →
  • Heart / cardiovascular diseaseHigh blood pressure

    Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)

    Studying how vitamin C affects blood vessel function in obese adults with insulin resistance and

    📍 University of Kansas Medical Center · Kansas City, KS · Get directions →

    The main purpose of research is to examine and understanding the development of hypertension in obese adults with insulin resistance. Findings from our studies will identify unique mechanisms that can be targeted to limit increases in vascular dysfunction and reduce the excessively high prevalence of hypertension and risk for cardiovascular disease (CVD).

    ✓ Study care freePhase 1Ages 35–65Learn more →
  • COPD (chronic lung disease)Asthma

    Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Pulmonary Diseases

    Testing the safety of an IV stem cell treatment for lung diseases like COPD and asthma

    📍 Medical Surgical Associates Center · St John's, · Get directions →

    This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of Pulmonary Diseases

    ✓ Study care freePhase 1Learn more →
  • Heart / cardiovascular diseaseKidney disease

    Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease

    Testing dapagliflozin with standard care on heart and lung function and blood metabolites in chronic

    📍 Northwestern University · Chicago, IL · Get directions →

    The goal of this study is to better understand the effects of a sodium-glucose transport protein 2 inhibitor, dapagliflozin, added on to standard of care on heart and lung function and circulating metabolites (substances created when our bodies break down food, drugs, or its own tissues) in patients with chronic kidney disease.

    ✓ Study care freePhase 1Ages 18–85Learn more →